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Purpose: Patients with premature peripheral vascular disease may respond ifferently than 
their older counterparts. To determine the impact of early onset of atherosclerosis on 
outcome, we decided to compare a group of these patients with a group of patients with 
typical onset of atherosclerosis with regard to early complications, indications for 
intervention, site of disease at initial presentation (aortoiliae, infrainguinal, or cerebrovas- 
cular), and long-term outcomes (secondary revascularization, amputation, and death). 
Method: All patients younger than 50 years old requiring operative intervention between 
1987 and 1992 were retrospectively compared with a group of patients greater than 60 
years old, randomly selected from patients who underwent operation during the same time 
period. Patients were evaluated and compared for indications, risk factors, and early and 
late outcomes. 
Results: Patients with early onset atherosderosis at the aortoiliac or infrainguinal level had 
a higher late amputation rate (17% versus 3.9%, p = 0.02) and poorer overall outcome than 
their older cohorts. Patients with cerebrovascular disease in both cohorts had similarly 
good prognoses. 
Conclusion: Aortoiliac or infrainguinal disease diagnosed in patients less than 50 years of 
age portends a poorer outcome than does similar disease in an older patient population. 
(J VAse SvR~ 1996;23:576-81.) 
Atherosclerosis is typically thought of as a disease 
process of the elderly population. However, a sub- 
group of patients are diagnosed early, betbre the age 
of 50, with significant occlusive disease. The factors 
responsible for this premature atherosclerosis are not 
well delineated but have become an area of increas- 
ing interest over recent years. Young patients may 
not respond in the same way that their older coun- 
terparts do to various surgical interventions. The 
outcome of  these patients has been suggested to be 
worse than their older counterparts. To further 
evaluate the impact of  premature atherosclerosis on 
long-term outcome, we decided to study the early 
complications and long-term need tbr subsequent 
revascularization, amputation, and late death in a 
group of these patients. We also evaluated the impact 
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of the site of initial disease presentation on long-term 
outcomes. 
METHODS 
A retrospective review of all paticnts under 50 
years of age who underwent operative intervention 
tbr vascular occlusive disease between 1987 and 1992 
was undertaken. A group of patients over 60 years of 
age, with the same disease distribution as the younger 
patients (determined by level of operation, anglo- 
grams, and noninvasive study results), served as 
control subjects. Control subjects were randomly 
selected from patients greater than 60 years of age 
who underwent operative intervention by the same 
surgeons during the same time period as patients with 
premature peripheral vascular disease (PVD). Patient 
charts were examined for indications for operation, 
procedures performed, complications, bypass patency 
rates, subsequent operations, early and late major 
amputations, early and late mortality rates, and risk 
factors. Risk factors evaluated included history of 
smoking, diabetes mellitus, sex, hypertension, coro- 
nary artery disease, and other medical comorbidities. 
Patients with aneurysmal disease, trauma, or other 
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nonocclusive arterial disorders were excluded from 
the study. Young patients were compared with refer- 
ence to location of initial disease at presentation, 
history of smoking, diabetes, and sex. Young and old 
patients were evaluated with regard to overall out- 
come (death, amputation, graft failure, cerebrovascu- 
lar accident, myocardial int)rction, or recurrent symp- 
toms), mortality rate, amputation, and the need for 
reoperation. Patients were divided into three groups 
on the basis of the initial site of intervention: A, 
aortoiliac; B, infrainguinal; and C, cerebrovascular. 
Patients with cerebrovascular disease were evaluated 
separately tbr risk factors, demographics, and out- 
comes. Patients were considered smokers if they were 
currently smoking or had quit smoking within the 
previous 2 years. Coronary artery disease was consid- 
ered to be present with current or historical evidence 
of congestive heart failure, ongoing angina, myocar- 
dial infarction, or previous coronary artery bypass 
grafting. Statistical analysis was by chi-squared, mul- 
tiple linear regression, stepwise logistic regression, 
and life-table analysis. Significance was taken at the 
p < 0.05 level. Data are expressed with standard 
deviation. 
RESULTS 
A total of 76 young patients and 76 control 
subjects (age >60 years at first operation) were evalu- 
ated. There were 29 patients in group A, 26 patients 
in group B, and 21 patients in group C in both young 
and old cohorts. Patients in the older cohort were 
specifically chosen to match the distribution of disease 
tbund in the study group. In patients with premature 
atherosclerosis, mean follow-up was 62 + 48 months. 
In the older cohort of patients, mean follow-up was 
33.4 + 27 months. Demographic data on the two 
groups are presented in Table I. As expected, the 
study group was significantly younger at the time of 
their initial surgery than were the control sub- 
jects (43.7 + 5.1 years versus 69.7 + 6.4 years, p < 
0.0001). There was not a statistically significant 
difference in hypertension, or diabetes between the 
two groups, although juvenile-onset diabetes was 
more frequent in patients with premature PVD. 
History of smoking was significantly more common 
in the younger patients (91% versus 69%, p < 0.05). 
Younger patients also were more often men and more 
frequently underwent operation for limb salvage 
(85% versus 60%, p < 0.05), In contrast, symptomatic 
coronary artery disease was more prevalent in the 
older cohort (60% versus 29%, p < 0.005). Five per- 
cent of older patients had multilevel disease at time of 
presentation, ascompared to 11.8% of younger pa- 
tients. 
There were no perioperative deaths in the study 
group nor in the older group. The 5-year mortality 
rate by life-table analysis was slightly increased in the 
study group, but this did not achieve statistical 
significance (26% versus 16.7%, p = NS, 10% confi- 
dence intervals). However, when compared with the 
expected survival rate by the United States National 
Center for Health Stats Vital Statistics, ~ patients with 
premature PVD experience a significantly greater 
mortality rate (26% vs 1.73%, p < 0.0001) than ex- 
pected, whereas older patients only have a minimally 
increased mortality rate (16.7% vs. 15.04%, p = NS) 
when compared to the overall population. Early 
amputation was also more common, although not 
statistically significant, in the younger patients with 
PVD (groups A and B), than in their corresponding 
control subjects ( 11.5% versus 2.6%, p = NS), whereas 
late amputation rates, by life-table analysis, were 
significantly increased in the younger patients (39.5% 
versus 8.3%, p= 0.005, 10% confidence intervals). 
This is consistent with the higher incidence of limb 
salvage procedures in the young patients. However, 
even when older patients initially underwent inter- 
vention for limb salvage, only 9.1% eventually re- 
quired amputations. Secondary procedures were re- 
quired in about half of the patients in both study 
groups and in control subjects and were perfbrmed 
tbr progression of disease rather than graft failure in 
the vast majority (91%) of patients. Overall poor 
outcome was significantly increased in the study 
group (39.5% versus 23.7%, p = 0.05). 
Factors influencing late outcome 
Sex, history of smoking, hypertension, and a 
history of coronary artery disease did not influence 
the need fbr late amputation, secondary revascular- 
ization, or late death (Table II). Diabetes was signifi- 
cantly associated with the need for multiple intcrven 
tions (p < 0.05), late amputation (38% versus 14%, 
p < 0.02), and death (25% versus 8%, p < 0.02) in 
patients with premature atherosclerosis but not in the 
older cohort with typical onset atherosclerosis. Eleven 
patients in the young cohort had juvenile-onset 
diabetes, and eight were insulin dependent. Eleven 
patients in the older cohort had insulin-dependent 
diabetes. Patients with juvenile-onset diabetes did not 
have a significantly higher rate of multiple interven- 
tions (36%), amputations (27%), or deaths ( 18 %) than 
did patients with adult-onset diabetes. 
Multiple interventions significantly increased late 
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Table I .  Demographics of young and old patients with lower extremity PVD 
Young patients Old patients Sign{ficance 
Hypertension 23 (42%) 29 (53%) NS 
CAD 16 (29%) 33 (60%) 0.005 
Smoking 50 (91%) 38 (69%) 0.01 
Diabetes 19 (35%) 20 (36%) NS 
Male sex 47 (85%) 34 (62%) 0.01 
Operation fbr limb salvage 47 (85.5%) 36 (66%) 0.013 
CAD, Coronary artery discasc. 
Table II. Factors influencing late complications in young patients 
Late mortality rate Overall amputauon rate Revascularization 
Hypertension 6/40 (15%) 8/40 (20%) 11/40 (27.5%) 
History of smoking 5/69 (7.2%) 13/69 (18.8%) 19/69" (27.5%) 
Male sex 6/62 (9.7%) 12/62 (19.4%) 18/62 (29%) 
Diabetes 6/24* (25%) 9/24 t (37.5%) 10/24 (41.7%) 
Infrainguinal disease 4/26 (15.4%) 11/26" (42.3%) 19/26:~ (73.1%) 
Total 8 15 21 
*p < 0.05. 
tP  < 0.006. 
;tp < 0.0001. 
morbidity and mortality rates. Twenty-one young pa- 
tients underwent multiple procedures. When young 
patients required multiple revascularizations ~br limb 
salvage, eventual amputation occurred in 41.7%, 
compared with 13.5% (p = 0.014) of patients not re- 
quiring multiple interventions. The late mortality rate 
was also increased in individuals undergoing multiple 
procedures, with a 33% versus a6% mortality rate with 
single interventions. Mean fbllow-up was significantly 
longer in patients undergoing multiple procedures 
(62.2 months vs 40.5 months), as would be expected. 
However, in most patients who experienced compli 
cations, the complication developed within 2 to 3 
years after the initial intervention, well within the av- 
erage follow-up. The mean time to complication or 
death was less than 30 months in both groups. 
Location of initial disease was also related to 
outcome (Table III). Patients who initially were 
diagnosed with infi'ainguinal disease were more likely 
to require additional procedures in both young and 
old cohorts. In the younger patients, infrainguinal 
disease was also associated with a higher late amputa- 
tion rate and a poorer long-term outcome than either 
aortoiliac or cerebrovascular disease. 
Patients with cerebrovascular disease did similarly 
well in both young and old cohorts. Both young and 
old patients with cerebrovascular disease had a similar 
incidence of symptomatic disease, 57% for older 
patients and 62% for younger patients. Secondary 
procedures were required in only 14.3% of young 
patients and 9.5% of old patients (p -- NS). Reopera- 
tion was performed as a result of recurrent stcnosis in 
only one (4.8%) of  the older cohort and in none of the 
younger patients. There were no early strokes in either 
group, with only one young patient having a late 
cerebrovascular accident. Only one patient who was 
diagnosed with cerebrovascular disease died during 
the 5-year fbllow-up in both cohorts. 
D ISCUSSION 
The clinical profile of a young patient with ath 
erosclerosis  a man with a history of smoking. The 
incidence of diabetes and hypertension is similar to 
that in later onset atherosclerosis. Fourteen percent of 
our young patients had juvenile-onset diabetes. In our 
experience, diabetes and smoking are a particularly 
virulent combination. It was of great interest hat 
symptoms of coronary atherosclerosis was seen in 
only 29% of young patients, despite the advanced 
nature of the atherosclerosis in the peripheral and 
cerebral vascular beds. The markedly increased mor- 
tality rate in young patients of age-adjusted mortality 
statistics points out the poor prognosis for this patient 
group. ~ Although we have no proof of subclinical 
cardiac ischemia in these young patients, routine 
cardiac screening for occult disease is an area in need 
of investigation. 
History of smoking was significantly more com- 
mon in patients with premature atherosclerosis, 
whereas symptomatic oronary artery disease was 
more frequently identified in older patients. History 
of smoking was found to be a significant risk factor for 
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Table II I . Life-table analysis of  late outcome (5-year) related to disease location 
Aortoiliac InJ?ainguinal Significance (p) 
Late factors Young Old Young Old Young Old 
Secondary vascular econ- 19.2% 50.5% 79% 49% 
structions 
Major amputations 37.6% 6.25% 43.1% 11.35% 
5-year mortality rate 18.2% 15.66% 27.7% 20% 
p < 0.0001 NS 
NS NS 
NS NS 
multiple interventions. Although we were unable to 
show history of smoking as a major risk factor in 
amputation or death, this may be due to the high 
prevalence of smoking in patients with premature ath- 
erosclerosis, leaving a very small group of nonsmok- 
ers fbr comparison. Smoking has been identified as 
a significant risk fhctor in all major studies 
of premature atherosclcrotic disease. 2q2 The exact 
mechanism by which smoking impacts on these in- 
dividuals and why certain individuals seem to be 
more susceptible to the deleterious effects of smok- 
ing is not fully understood, z3Smoking is known to 
have an impact on the cholesterol metabolism, in- 
cluding a reduction of plasma high-density lipopro- 
tein levels, ~4 as well as to directly affkct the vascular 
endothelial and smooth muscle cells) "~ Smoking is 
also known to increase plasma fibrinogen levels. ~ 
Furthermore, smoking is associated with an in- 
creased rate of graft fa i lure .  17'18 
Hypertension was most common in patients re- 
quiring cerebrovascular reconstructions. Hyperten- 
sion has not been found to bc as prevalent in patients 
with early onset athcrosclerosis, occurring in 6% to 
63%, when compared with patients with typical onset 
atherosclerosis. 2q2ag'2~ In our series, hypertension 
was equally prevalent in both age groups. 
Diabetes was present in about one third of both 
young and old patients with PVD. Patients with 
diabetes were admitted more f?cquently with distal, 
infrainguinal disease and less commonly with ccre- 
brovascular disease. Young patients with diabetes also 
showed increased rates of early and late major ampu- 
tation and late mortality. Diabetes is also known to 
impact adversely on the lipid metabolism 2~ and, in 
combination with smoking, may provide a particu- 
larly detrimental environment. 
The presence of  risk factors that might predispose 
some individuals to premature atherosclerosis has 
been a subject of increasing interest over recent years. 
In our series at least one major risk fhctor was present 
in 97% of all patients, and multiple risk factors were 
present in 67% of patients. 
An increased rate of amputation, ranging from 8% 
to 71% after intervention fbr PVD, has frequently 
been identified in patients with early onset atheroscle- 
rosis.4 6,22,23 Late mortality rates have also been in- 
creased with 5-year mortality rates of  6.6% to 
20%.2,3,6 8,19,20 Whereas the S-year survival rate by 
life-table analysis was similar in both groups, this 
needs to be taken in the context of  the increased age 
and increased rate of coronary artery disease in the 
older control group. Age-adjusted mortality rates 
suggest a marked increase in deaths for the younger 
atherosclerotic population versus only a minimal 
decrease in life expectancy fbr patients with typical- 
onset athcrosclerosis. Most of these deaths are attrib- 
uted to heart-related orother vascular complications. 
Wc have found that patients with premature PVD fare 
significantly worse than their older cohorts with 
regard to increased rates of rcoperation fbr limb 
salvage, (p < 0.05), late amputation, (p < 0.02), and 
overall poor long-term outcomes, (p < 0.05). 
Young patients in our series were diagnosed with 
a wide array of vascular lesions fairly evenly distributed 
among cerebrovascular, ortoiliac, and distal disease 
locations. The presence ofcerebrovascular disease in 
the young patient has not been noted in prior reports. 
The impact of the initial location of disease presenta- 
tion on late outcome has not previously been evalu- 
ated. In our series, the presence ofaortoiliac or lower 
extremity disease implied significantly diffkrent out- 
comes than does the presence of premature cere- 
brovascular occlusive disease. Our series does differ 
from most of those in the literature in that 88% of our 
patients with premature atherosclerosis underwent 
operation for limb-threatening disease, whereas most 
patients (60% to 83%) with premature atherosclerosis 
presented in most series undergo intervention for 
claudication. "~'6,1~ In our patients, initial presenta- 
tion with infrainguinal disease significantly increased 
the need for subsequent revascularizations and the 
risk of amputation. Poor long-term outcome is com- 
mon in these patients with the early onset of distal 
disease. We have found that the outlook for patients 
diagnosed with aortoiliac occlusive disease is also 
poor, with more than half of the patients requiring 
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multiple procedures, 20.7% requiring major amputa- 
tions, and a 17.2% 5-year mortality rate. 
In our series, cerebrovascular esions were associ- 
ated with a more benign course. Patients with early- 
onset cerebrovascular disease did not differ from 
typical onset cerebrovascular disease in their long- 
term outcome. Secondary procedures were required 
in only 14.3% of young patients and 9.5% of older 
patients, with only one patient having development of
recurrent cerebral symptoms and restenosis. Only one 
patient (4.7%) died during the 5-year follow-up in 
both the young and old cohorts with initial presen- 
tation with cerebrovascular disease. Patients with 
cerebrovascular occlusive disease as the presenting 
sign of premature athcrosclcrosis can safely undergo 
operation with good long-term results. The reasons 
for these differences in outcome by disease distribu- 
tion is unclear. We did find a lower incidence of 
diabetes in our young patients with cerebrovascular 
disease. Diabetes is associated with increased lipid 
abnormalities and decreased longevity and was a 
major determinant of poor outcome in our series. 
Lipid data were not uniformly available in the retro- 
spective review, and therefore no conclusion on the 
impact of liPid abnormalities could be drawn. 
A prospective study of  patients with early athero- 
sclerosis in different disease distributions i  needed to 
elucidate the differences in outcome and perhaps to 
identify individuals at higher risk for poor long-term 
survival. Certainly, the control of  modifiable risk 
factors may be very important in the long-term 
prognosis of individuals with lower extremity disease 
and aortoiliac disease. Intense investigation i to risk 
factor modification analysis and control ofhypercho- 
lesterolemia, hypertriglyceridemia, elevated oxidized 
lipids, and hypercoagulable states is needed if we are 
to improve on the dismal outcomes in this group of 
patients. 
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D ISCUSSION 
Dr. Daniel B. Walsh (Lebanon, N.H.). Dr. Harris and 
colleagues have brought us data demonstrating that young 
patients with diabetes undergo early and late amputation 
and die at greater ates than a comparable group of older 
patients. Smoking is also a likely predictor of poor outcome 
in these young patients. However, this series was so domi- 
nated by patients with a history of smoking that demon- 
stration of smoking as an independent predictor was not 
possible. Finally, young patients with lower cxtremi~" symp- 
toms, whether caused by infi'ainguinal oraortoiliac disease, 
had poor and complicated long term outcomes. These 
findings are similar to those reported in the past by groups 
from Texas and South Carolina. To any experienced vascular 
surgeon they seem intuitively correct. 
The issue with regard to cause of these poor outcomes 
in this younger patient group requires closer examination. 
In a Cleveland Clinic series of patients with lower extremity 
disease, only 13% of their patients had normal lipid or 
lipoprotein profiles. Can you give us some insight into the 
lipid status of your young patient group? Several investiga- 
tors have found a high incidence of antiphospholipid 
syndrome among younger patients with arterial disease. 
There are also abundant reports of natural anticoagulant or 
fibrinolytic deficiencies in younger patients with vascular 
disease, particularly problems with antithrombin III, pro- 
tein C, protein S, heparin cofactor II, apolipoprotein B, and 
very low density lipoprotein. Have you any data regarding 
these abnormalities in your patient group? 
Another interesting observation was that of Valentine t 
al., who fbund that arterial sizc, particularly small aortic 
size, was a significant prcdictor of poor outcome. Can vou 
give us any insight into the relative sizes of the aortoiliac and 
infraingtfinal rterics involved between your younger and 
older groups of patients with atherosclerosis? 
Dr. Linda M. Harris. Unlbrtunately, we did not have 
a chance to evaluate the size of the aorta or the vcssels and 
compare the two groups, so we don't know whether thcre 
was any significant diffkrence in vessel sizc. 
With regard to thc first question, we did look at a subset 
ofthesc patients. Unfbrtunatcl B because itwas a retrospec- 
tive study, we did not havc complete lipid data on all of the 
patients. Wc did obtain bypercoagulable and lipid data on a 
subgroup of patients who wcre still available for analysis. 
When we looked at this subgroup, we fbund that the 
routine lipid profiles werc only minimally elevated from a 
control group. So if you examined thc younger patients, 
their normal cholesterol, high density lipoprotein and low- 
density lipoprotein levels were not markedly diffcrent, 
although they wcre slightly clevated (in thc 200 to 220 
rangc). However, we also looked at oxidized lipids and 
found that these were markedly increased in the younger 
age population comparcd with both control subjects of 
similar age and with patients with older onset ofatherosclc- 
rosis. 
We also looked at hypercoagutable states in this sub- 
group and only found them to be present in about 13% to 
20% of patients. I understand that there are some groups 
that seem to find it to bc a more prevalent problem. We did 
not study platelet abnormalities, and we didn't study 
homocystinuria, but we did look at the most D*pical 
hypercoagutable states, including deficiency in protein C, 
protein S, antithrombin III, and a few other fhctors. We do 
think that these younger patients need to be aggressively 
treated fbr whatever hypercoagulablc or lipid abnormalities 
that they do have. We are currently prospectively studying 
these younger patients to determine what wc can modiB,, to 
possibly improve their dismal outcomes. 
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